Hexoprenaline
Title: Hexoprenaline
CAS Registry Number: 3215-70-1
CAS Name: 4,4¢-[1,6-Hexanediylbis[imino(1-hydroxy-2,1-ethanediyl)]]bis-1,2-benzenediol
Additional Names: a,-[hexamethylenebis(iminomethylene)]bis[3,4-dihydroxybenzyl alcohol]; N,N¢-bis[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]hexamethylenediamine
Manufacturers' Codes: BYK 1512
Molecular Formula: C22H32N2O6
Molecular Weight: 420.50
Percent Composition: C 62.84%, H 7.67%, N 6.66%, O 22.83%
Literature References: b2-Adrenergic agonist. Prepn: O. Schmid et al., AT 241436; eidem, US 3329709 (1965, 1967, both to OSSW); Schmid et al., DE 1215729 (1966 to Lentia GmbH). Pharmacology: Thiede et al., Arzneim.-Forsch. 21, 416 (1971). Clinical studies: Schindl, ibid. 20, 1755 (1970); several authors in Wien. Klin. Wochenschr. 83, 75, 80, 101, 114, 117, 130 (1971). Clinical evaluation for interruption of labor: J. Lipshitz et al., J. Reprod. Med. 31, 1023 (1986).
Properties: Crystals, mp 162-165° (hemihydrate).
Melting point: mp 162-165° (hemihydrate)
 
Derivative Type: Dihydrochloride
CAS Registry Number: 4323-43-7
Manufacturers' Codes: ST-1512
Trademarks: Ipradol (CL Pharma)
Molecular Formula: C22H32N2O6.2HCl
Molecular Weight: 493.42
Percent Composition: C 53.55%, H 6.95%, N 5.68%, O 19.46%, Cl 14.37%
Properties: Crystals from methanol-ether, mp 197.5-198°.
Melting point: mp 197.5-198°
 
Derivative Type: Sulfate
CAS Registry Number: 32266-10-7
Trademarks: Bronalin (Byk-Liprandi); Delaprem (Savage); Etoscol (Byk Gulden); Gynipral (Chemie Linz); Ipradol (CL Pharma); Leanol (Yoshitomi)
Molecular Formula: C22H32N2O6.H2SO4
Molecular Weight: 518.58
Percent Composition: C 50.95%, H 6.61%, N 5.40%, O 30.85%, S 6.18%
Properties: Crystals from water-alcohol, mp 222-228°.
Melting point: mp 222-228°
 
Therap-Cat: Bronchodilator; tocolytic.
Keywords: ?Adrenergic Agonist; Bronchodilator; Ephedrine Derivatives; Tocolytic.

Others monographs:
DendrotoxinsBeclamidePiperonalRitanserin
AgrocybinOrange PeelPolonium DioxideTranexamic Acid
XanthoneOil of BayLaurelineDiisoamylamine
CorybulbineSepimostatDapsoneMercurophen
©2016 DrugLead US FDA&EMEA